Standard BioTools amends 8-K to file mass cytometry sale agreement with Multiplex Bio
LAB•Amended 8-K adds sale agreement
Standard BioTools filed an amended Form 8-K to correct its July 28, 2026 report by adding the Share and Asset Purchase Agreement.
The agreement covers the planned sale of its mass cytometry business to Multiplex Bio.
No other changes were made to the original 8-K.
